Codice QR

Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study

Abstract Background Pemafibrate, a selective PPARα modulator, has the beneficial effects on serum triglycerides (TGs) and very low density lipoprotein (VLDL), especially in patients with diabetes mellitus or metabolic syndrome. However, its effect on the low density lipoprotein cholesterol (LDL-C) l...

Descrizione completa

Salvato in:
Autori principali: Ichiro Komiya, Akira Yamamoto, Suguru Sunakawa, Tamio Wakugami
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMC 2021-02-01
Serie:Lipids in Health and Disease
Soggetti:
Low density lipoprotein cholesterol
Pemafibrate
Small
Dense LDL
Triglycerides
Type 2 daibetes
Accesso online:https://doi.org/10.1186/s12944-021-01434-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi